Electro-hyperthermia (EHT) is a supportive oncology modality that uses heat generated by electrical currents to selectively target cancer cells while sparing healthy tissues. Also known as oncothermia, it works alongside conventional oncology care to complement chemotherapy and radiation.
How It Works
EHT uses radiofrequency (RF) electromagnetic waves to heat cancerous tissues to between 40°C and 44°C. Cancer cells' higher metabolic rate and disrupted structure make them more susceptible to thermal effects. Modulated electric fields target cancer cells more precisely, causing apoptosis (programmed cell death), impaired cell division, and reduced blood flow to the tumour.
EHT may also stimulate an immune response by prompting tumour cells to release antigens, helping the immune system respond more effectively.
The Procedure
Preparation
Patient lies on a treatment bed; electrodes placed near the tumour site.
RF Application
Radiofrequency waves delivered through electrodes, generating targeted heat.
Monitoring
Temperature carefully monitored. Sessions last 30–90 minutes.
Repeat Sessions
Often administered multiple times over several weeks.
Key Benefits
Selective Targeting
Focuses on tumour tissue, reducing damage to surrounding healthy cells.
Non-Invasive
No surgery or incisions. Well-tolerated, especially for patients avoiding more invasive procedures.
Complements Conventional Care
Sensitises cancer cells to chemotherapy and radiation, supporting better outcomes.
Minimal Side Effects
Mild skin irritation possible; severe effects are uncommon.
Possible Side Effects
EHT should only be performed by trained healthcare professionals in a controlled medical setting.
HBOT is a supportive treatment in which patients breathe 100% oxygen in a pressurised chamber. It raises oxygen levels in blood and tissues, supporting healing, reducing inflammation, and promoting tissue repair. Its integration into oncology supportive care is actively explored.
Key Benefits in Oncology Support
Tumour Oxygenation
May improve oxygenation of hypoxic tumour cells, supporting their response to radiation and chemotherapy.
Radiation Complement
Increased oxygen levels around the tumour may support the efficacy of radiation therapy.
Reduces Radiation Injury
Supports recovery from late radiation-induced injuries like osteoradionecrosis and soft tissue necrosis.
Wound Healing
Supports post-surgical recovery, especially where prior radiation or chemotherapy has compromised healing.
Chemo Side Effects
Shows promise in alleviating neurotoxicity and mucositis by reducing inflammation and supporting tissue repair.
Evidence Areas
Radiation Injury: Widely used to support recovery from radiation-induced tissue damage in head and neck, breast, and pelvic cancers.
Tumour Hypoxia: Promising preclinical and clinical results; larger studies ongoing.
Wound Healing: Shown to significantly support post-surgical recovery in patients with compromised healing.
IV curcumin may help reduce inflammation and support immune function as an adjunct to standard oncology care. High-dose IV vitamin C may support quality of life, reduce chemotherapy side effects, and help boost immune function.
IV Vitamin C & Chemotherapy in Pancreatic Cancer
A 2025 systematic review found that adding IV vitamin C to standard chemotherapy and/or radiation may support survival outcomes and treatment tolerance, with increased completion rates and minimal added toxicity.
Waleed Mir et al. JCO 43, e16396 (2025).IV Curcumin with Paclitaxel in Breast Cancer
IV curcumin (300mg weekly) combined with paclitaxel showed superior response rates vs. paclitaxel-placebo in advanced and metastatic breast cancer. Patients reported significantly higher physical performance with curcumin. No major safety concerns.
Saghatelyan T, et al. Phytomedicine. 2020;70:153218.IV Vitamin C in Palliative Care
Patients reported significantly lower fatigue, nausea/vomiting, pain, and appetite loss following vitamin C. Considered a safe approach to supporting quality of life in patients with advanced cancer.
Yeom CH, et al. J Korean Med Sci. 2007;22(1):7-11.IV Vitamin C in Colorectal Cancer
May be beneficial in patients with metastatic colorectal cancer harbouring RAS mutation (subgroup analysis: median PFS 9.2 vs. 7.8 months).
Wang F, et al. VITALITY Study. Clin Cancer Res. 2022;28(19):4232.Mistletoe therapy is a plant-based supportive therapy administered by gentle injection or intravenously as part of an immune support protocol. Widely used in integrative oncology to support resilience, strengthen immune function, and improve tolerance of conventional cancer treatments.
Clinical trials and long-term European experience have shown quality-of-life benefits, with many patients reporting better energy, improved sleep, and a greater sense of wellbeing. At Sanctura, it is provided as part of a personalised care plan, always alongside standard medical care.
Mistletoe in Breast Cancer Quality of Life
A systematic review and meta-analysis found a clinically relevant, medium-sized effect of mistletoe extracts on quality of life in breast cancer patients, possibly based on immuno-modulating effects during chemotherapy.
Loef M, Paepke D, Walach H. Integr Cancer Ther. 2023;22:15347354231198074.While not all immunotherapy modalities are delivered directly on site, our specialist network is firmly positioned within the integrative oncology framework — closely aligned with conventional guidelines, current clinical trials, and innovative approaches for rare or complex cases.
Patients supported alongside immunotherapy at Sanctura often receive complementary therapies such as electro-hyperthermia, IV vitamin C and curcumin, mistletoe, HBOT, and photobiomodulation. Hyperthermia may help influence the tumour environment and contribute to a possible abscopal effect when combined with standard-of-care treatments.
Immunotherapy Modalities
Checkpoint Inhibitors
Block proteins cancer cells use to evade the immune system, restoring its ability to recognise and respond.
CAR-T Cell Therapy
A patient's T-cells are genetically engineered to better recognise and respond to cancer cells.
Cytokine Therapy
Synthetic proteins administered to support and boost the immune system's response.
Investigational Vaccine-Based Approaches
Designed to stimulate the immune system to recognise specific antigens found on cancer cells.
Monoclonal Antibodies
Lab-created molecules targeting specific proteins in cancer cells to help the immune system find and respond to them.
Oncolytic Virus Therapy
Genetically modified viruses that selectively infect cancer cells and can stimulate a broader immune response.
Comprehensive supportive therapies provided alongside chemotherapy and radiation to help manage side effects, improve quality of life, and support tolerance. Our network provides conventional oncology interventions; our supportive care helps patients navigate their journey with greater comfort.
What's Included
- Nutritional Support — maintaining weight, strength, and immunity during treatment
- Pain Management — addressing neuropathy, inflammation, and discomfort
- Psychological Support — counselling, CBT, and emotional support for patients and families
- Immune Support — helping maintain immunity against treatment-related suppression
- Hydration & Electrolyte Balance — IV fluids and electrolyte therapies where needed
- Exercise & Physical Therapy — tailored programmes to reduce fatigue and improve strength
- Complementary Therapies — supporting the body's natural processes alongside conventional care
- Bone & Joint Health — strategies to support bone density and reduce fracture risk
Benefits
Improved Tolerance
Helps patients complete their full course of conventional treatment.
Enhanced Quality of Life
Significantly improves daily comfort and emotional wellbeing.
Prevents Complications
Reduces risk of infections, dehydration, and nutritional deficiencies.
Faster Recovery
Helps patients return to normal activities sooner after treatment.
PDT is a minimally invasive, localised supportive oncology modality using light-sensitive drugs and light to act on cancer cells. CTC (Circulating Tumour Cell) analysis provides non-invasive real-time monitoring to guide supportive care. The two can be combined as part of a comprehensive integrative approach.
Photodynamic Therapy (PDT)
A photosensitizing agent is administered orally, intravenously, or topically. After 24–72 hours, the area is exposed to specific light wavelengths (lasers, LED, or fibre-optic cables). This activates the photosensitizer, generating reactive oxygen species localised to the target tissue, sparing surrounding healthy tissues.
CTC Analysis & Monitoring
Circulating Tumour Cells (CTCs) are cells that have detached from the primary tumour and entered the bloodstream. Advanced "liquid biopsy" techniques detect CTCs from blood samples, enabling real-time monitoring and targeted supportive therapy adjustments.
Key Advantages
Minimally Invasive
No surgery. Often outpatient, avoiding risks of invasive procedures.
Targeted
Light directed precisely at the target site, sparing surrounding tissues.
Real-Time Monitoring
CTC analysis enables non-invasive tracking of the body's response.
Combination Potential
Can complement other supportive modalities including surgery and immune approaches.
A gentle, non-invasive supportive treatment in which pure medical-grade hydrogen gas is inhaled through a nasal cannula or mask. It helps neutralise harmful free radicals, supports healthy mitochondrial function, and strengthens cellular resilience during oncology care.
By reducing oxidative stress, calming inflammation, and supporting cellular energy, this evidence-informed therapy works safely alongside chemotherapy, radiotherapy, and other medical care — easing fatigue, enhancing energy, and improving overall comfort and wellbeing.
Available through regular sessions at our clinic — often alongside HBOT, IV vitamin C, and other infusions — or as a home-based option with a rented machine.
A holistic approach to integrative oncology support, aiming to improve physical, emotional, mental, and social wellbeing alongside standard cancer care. Focuses on managing the effects of conventional treatment to enhance quality of life and promote long-term health.
- Physical Wellbeing — addressing fatigue, pain, nausea, neuropathy; tailored exercise and nutritional counselling
- Emotional & Psychological Support — counselling, CBT, mindfulness, relaxation techniques for patients and families
- Social Wellbeing — connecting patients with support groups, social workers, and community resources
- Spiritual Wellbeing — chaplaincy, meditation, and spiritual counselling to nurture sense of purpose
- Cognitive Wellbeing — rehabilitation strategies to manage "chemo brain" and cognitive effects
- Financial Wellbeing — guidance on insurance navigation and financial support programmes
- Survivorship Care — long-term monitoring, managing late effects, and healthy lifestyle planning after active care
- Palliative & End-of-Life Care — symptom management and spiritual support for patients with advanced cancer
Holistic practices that integrate physical, mental, and spiritual wellbeing to support patients throughout their oncology journey — managing physical symptoms, coping with psychological challenges, and nurturing spiritual resilience.
Mind Practices
- Mindfulness & Meditation — present-moment awareness to manage stress and anxiety
- Cognitive Behavioural Therapy (CBT) — identifying and shifting negative thought patterns
- Mental Health Counselling — processing fears and emotions with trained therapists
- Visualisation & Guided Imagery — supporting positive inner states
- Support Groups — shared learning, validation, and reduced isolation
Body Practices
- Yoga — combining movement, breathing, and meditation
- Tai Chi & Qigong — slow, flowing movement with deep breathing and meditative focus
- Massage Therapy — relieving muscle tension and improving circulation
- Acupuncture — supporting energy flow, reducing nausea, pain, and fatigue
- Tailored Exercise Programmes — adapted to each patient's condition and stage
Soul Practices
- Spiritual Counselling — comfort aligned with personal faith or spiritual beliefs
- Meditation & Prayer — inner peace and a sense of connection
- Art Therapy — creative expression to process emotions and find meaning
- Nature Therapy (Ecotherapy) — restoring peace and balance through time in nature
- Gratitude Practices — shifting focus from fear to meaning and appreciation
A metabolic approach to oncology support focuses on targeting the unique metabolic characteristics of cancer cells — using nutritional strategies and adjunctive interventions alongside conventional oncology care to support overall cellular health.
Key Strategies
- Reducing glucose availability — dietary approaches to limit the primary energy source many cancer cells rely on (the Warburg Effect)
- Mitochondrial support — targeting mitochondrial function to support normal cells while disrupting altered cancer cell metabolism
- Reducing inflammation & oxidative stress — chronic inflammation linked to cancer progression; metabolic strategies aim to regulate this
- Fasting & caloric restriction — may reduce growth signals (insulin, IGF-1) and complement conventional therapies
- Supplements & adjunctive interventions — evidence-informed approaches targeting cancer cell metabolism
Benefits
Supports Quality of Life
Reduces inflammation, manages treatment side effects, and helps boost energy.
Lower Toxicity Adjunct
Many metabolic interventions are less toxic than conventional treatments.
Complements Conventional Care
May support the effectiveness of chemotherapy and radiation.
Personalised Approach
Requires individual tailoring — integrated into your specific supportive care plan.
The gastrointestinal microbiome is increasingly recognised as a critical factor in oncology. These microbes interact with the immune system in ways that can influence cancer biology and the effectiveness of conventional oncology care.
Microbiome & Immune Regulation
Healthy gut microbes keep the immune system balanced. Gut bacteria produce short-chain fatty acids (SCFAs) like butyrate, which have anti-inflammatory properties and help regulate immune cells. Dysbiosis (microbiome imbalance) can weaken immune responses or contribute to chronic inflammation.
Gut Health & Conventional Oncology Care
- Immunotherapy — gut microbiome diversity is associated with better checkpoint inhibitor response in some studies
- Chemotherapy — certain bacteria can enhance the immune system's response to chemotherapy and influence drug efficacy
- Radiation — a healthy microbiome supports recovery from radiation-induced gut lining damage and side effects
Sanctura's integrative approach includes assessment and support of gut health as part of a holistic supportive care plan.